Lenalidomide in Diffuse Large B-Cell Lymphomas

by Annalisa Chiappella, Umberto Vitolo
Published 2012-01-01

FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT

by Alessia Castellino, Umberto Vitolo
Published 2017-01-01

Shifting Treatment Paradigms in Non-Hodgkin Lymphomas

by Dolores Caballero, Umberto Vitolo, Martin Dreyling, Roch Houot
Published 2017-08-01

Lenalidomide in the Treatment of Lymphoproliferative Disorders and Multiple Myeloma

by Anna Marina Liberati, Umberto Vitolo, Antonio Palumbo, Agostino Cortelezzi
Published 2013-01-01

Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?

by Annalisa Chiappella, Jennifer Crombie, Anna Guidetti, Umberto Vitolo, Philippe Armand, Paolo Corradini
Published 2019-10-01

A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA

by Laurie H. Sehn, Maurizio Martelli, Marek Trněný, Wenxin Liu, Christopher R. Bolen, Andrea Knapp, Deniz Sahin, Gila Sellam, Umberto Vitolo
Published 2020-06-01

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

by Cinzia Pellegrini, Anna Dodero, Annalisa Chiappella, Federico Monaco, Debora Degl’Innocenti, Flavia Salvi, Umberto Vitolo, Lisa Argnani, Paolo Corradini, Pier Luigi Zinzani, On behalf of the Italian Lymphoma Foundation (Fondazione Italiana Linfomi Onlus, FIL)
Published 2016-04-01